Antitumor activity of small double-stranded oligodeoxynucleotides targeting telomerase RNA in malignant melanoma cells

Oligonucleotides

Volumn 19, Issue 2, 2009, Pages 169-178

  Noreen, Faiza ^a   Heinrich, Jochen ^a   Moelling, Karin ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Center for Metropolitan Studies   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DOUBLE STRANDED ANTISENSE OLIGODEOXYNUCLEOTIDE; DOUBLE STRANDED SMALL INTERFERING RNA; OLIGODEOXYNUCLEOTIDE; RIBONUCLEASE H; SINGLE STRANDED ANTISENSE OLIGODEOXYNUCLEOTIDE; SMALL INTERFERING RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DESIGN; ENZYME INHIBITION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; LUNG METASTASIS; MELANOMA; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; LUNG NEOPLASMS; MELANOMA; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; RNA; TELOMERASE; TRANSFECTION;

MURINAE; MUS;

EID: 66249102322     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2008.0170     Document Type: Article

References (51)

1. ALLSOPP, R.C., CHANG, E., KASHEFIAAZAM, M., ROGAEV, E.I., PIATYSZEK, M.A., SHAY, J.W., and HARLEY, C.B. (1995). Telomere shortening is associated with cell division in vitro and in vivo. Exp. Cell Res. 220, 194-200.
2. ASAI, A., OSHIMA, Y., YAMAMOTO, Y., UOCHI, T.A., KUSAKA, H., AKINAGA, S., YAMASHITA, Y., PONGRACZ, K., PRUZAN, R., WUNDER, E., PIATYSZEK, M., LI, S., CHIN, A.C., HARLEY, C.B., and GRYAZNOV, S. (2003). A novel telomerase template antagonist (GRN163) as a potential anticancer agent. Cancer Res. 63, 3931-3939.
3. AUTEXIER, C., and LUE, N.F. (2006). The structure and function of telomerase reverse transcriptase. Annu. Rev. Biochem. 75, 493-517.
4. BISOFFI, M., CHAKERIAN, A.E., FORE, M.L., BRYANT, J.E., HERNANDEZ, J.P., MOYZIS, R.K., and GRIFFITH, J.K. (1998). Inhibition of human telomerase by a retrovirus expressing telo-meric antisense RNA. Eur. J. Cancer 34, 1242-1249.
5. BLACKBURN, E.H. (1991). Structure and function of telomeres. Nature 18, 569-573.
6. BLACKBURN, E.H. (2005). Telomerase and cancer. Mol. Cancer Res. 9, 477-482.
7. BLACKBURN, E.H., GREIDER, C.W., and SZOSTAK, J.W. (2006). Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat. Med. 10, 1133-1138.
8. BRAASCH, D.A., and COREY, D.R. (2002). Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry 41, 4503-4510.
9. CHAN, J.H., LIM, S., and WONG, W.S. (2006). Antisense oligonucleotides, from design to therapeutic application. Clin. Exp. Pharmacol. Physiol. 33, 533-540.
10. CHEN, X.J., ZHENG, W., CHEN, L.L., CHEN, Z.B., and WANG, S.Q. (2006). Telomerase antisense inhibition for the proliferation of endometrial cancer in vitro and in vivo. Int. J. Gynecol. Cancer 16, 1987-1993.
11. COUNTER, C.M., HAHN, W.C., WEI, W., CADDLE, S.D., BEIJERSBERGEN, R.L., LANSDROP, P.M., SEDIVY, J.M., and WEINBERG, R.A. (1998). Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA 95, 14723-14728.
12. FENG, J., FUNK, W.D., WANG, S.S., WEINRICH, S.L., AVILION, A.A., CHIU, C.P., ADMAS, R.R., CHANG, E., ALLSOPP, R.C., YU, J., LE, S., WEST, M.D., HARLEY, C.B., ANDREWS, W.H., GREIDER, C.W., and VILLEPONTEAU, B. (1995). The RNA component of human telomerase. Science 269, 1236-1241.
13. FOLINI, M., BERG, K., MILLO, E., VILLA, R., PRASMICKAITE, L., DAIDONE, M.G., BENATTI, U., and ZAFFARONI, N. (2003). Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase. Cancer Res. 63, 3490-3494.
14. FU, X.H., ZHANG, J.S., ZHANG, N., and ZHANG, Y.D. (2005). Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line. World J. Gastroenterol. 11, 785-790.
15. GLUKHOV, A.I., ZIMNIK, O.V., GORDEEV, S.A., and SEVERIN, S.E. (1998). Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides. Biochem. Biophys. Res. Commun. 248, 348-371.
16. GREIDER, C.W. (1991). Telomeres. Curr. Opin. Cell Biol. 3,444-451.
17. GREIDER, C.W., and BLACKBURN, E.H. (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413.
18. HAHN, W.C., COUNTER, C.M., LUNDBERG, A.S., BEIJERSBERGEN, R.L., BROOKS, M.W., and WEINBERG, R.A. (1999a). Creation of human tumor cells with defined genetic elements. Nature 400, 464-468.
19. HAHN, W.C., STEWART, S. A., BROOKS, M.W., YORK, S.G., EATON, E., KURACHI, A., BEIJERSBERGEN, R.L., KNOLL, J.H., MEYERSON, M., and WEINBERG, R.A. (1999b). Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5, 1164-1170.
20. HAO, Z.M., LUO, J.Y., CHENG, J., LI, L., HE, D., WANG, Q.Y., and YANG, G.X. (2005). Intensive inhibition of hTERT expression by a ribozyme induces rapid apoptosis of cancer cells through a telomere length-independent pathway. Cancer Biol Ther. 4, 1098-1103.
21. HOLT, S.E., and SHAY, J.W. (1999). Role of telomerase in cellular proliferation and cancer. J. Cell Physiol. 98, 677-683.
22. JENDIS, J., STRACK, B., and MOELLING, K. (1998). Inhibition of replication of drug-resistant HIV type 1 isolates by polypurine tract-specific oligodeoxynucleotide TFO A. AIDS Res. Hum. Retroviruses 14, 999-1005.
23. JENDIS, J., STRACK, B., VOLKMANN, S., BONI, J., and MOELLING, K. (1996). Inhibition of replication of fresh HIV type 1 patient isolates by polypurine tract-specific self-complementary oligodeoxynucleotide. AIDS Res. Hum. Retroviruses 12, 1161-1168.
24. KARLSEDER, J., SMOGORZEWSKA, A., and de LANGE, T. (2002). Senescence induced by altered telomere state, not telomere loss. Science 295, 1635-1644.
25. KONDO, S., TANAKA, Y., KONDO, Y., HITOMI, M., BARNETT, G.H., ISHIZAKA, Y., LIU, J., HAQQI, T., NISHIYAMA, A., VILLEPONTEAU, B., COWELL, J.K., and BARNA, B.P. (1998). Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J. 12, 801-811.
26. KOSCIOLEK, B.A., KALANTIDID, K., TABLER, M., and ROWLEY, P.T. (2003). Inhibition of telomerase activity in human cancer cells by RNA interference. Mol. Cancer Ther. 2, 209-216.
27. KWOK, T., HELFER, H., ALAM, M.I., HEINRICH, J., PALVLOVIC, J., and MOELLING, K. (2009). Inhibition of influenza A virus replication by short double-standard oligodeoxynucleotides. Arch Virol 154, 109-114.
28. LEERS, M.P., KOELGEN, W., BJÖRKLUND, V., BERGMAN. T., TRIBBICK, G., PERSSON, B., BJÖRKLUND, P., RAMAEKERS, F.C., BJÖRKLUND, B., NAP, M., JÖRNVALL, H., and SCHUTTE, B. (1999). Immunocytochemical detection and mapping of cytokeratin 18 neo-epitope exposed during early apoptosis. J. Pathol. 187, 567-572.
29. LI, S., CROTHERS, J., HAQQ, C.M., and BLACKBURN, E.H. (2005). Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interferencemediated depletion of telomerase RNA. J. Biol. Chem. 280, 23709-23717.
30. LI, S., ROSEMBERG, J.E., DONJACOUR, A.A., BOTCHKINA, I.L., HOM, Y.K., CUNHA, G.R., and BLACKBURN, E.H. (2004). Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res. 64, 4833-4840.
31. LUE, N.F. (2004). Adding to the ends: what makes telomerase processive and how important is it? BioEssays 26, 955-962.
32. LUKOWIAK, A.A., NARAYANN, A., LI, Z.H., TERNS, R.M., and TERNS, M.P. (2001). The snoRNA domain of vertebrate telomerase RNA functions to localize the RNA within the nucleus. RNA 7, 1833-1844.
33. MATSKEVICH, A.A., ZIOGAS, A., HEINRICH. J., QUAST, S.A., and MOELLING, K. (2007). Short partially double-stranded oligodeoxynucleotide induces reverse transcriptase/RNase H-mediated cleavage of HIV RNA and contributes to abrogation of infectivity of virions. AIDS Res. Hum. Retroviruses 22, 1220-1230.
34. MATZEN, K., ELZAOUK, L., MATSKEVICH, A.A., NITZSCHE, A., HEINRICH, J., and MOELLING, K. (2007). RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides. Nat. Biotechnol. 25, 669-674.
35. McE ACHERN, M.J., KRAUSKOPF, A., and BLACKBURN, E.H. (2000). Telomeres and their control. Annu. Rev. Genet. 34, 331-358.
36. McELLIGOTT, R., and WELLINGER, R.J. (1997). The terminal DNA structure of mammalian chromosomes. EMBO J. 16, 3705-3714.
37. MERGNY, J.L., LI, J., LACROIX, L., AMRANE, S., and CHAIRES, J.B. (2005). Thermal difference spectra: a specific signature for nucleic acid structure. Nucleic Acids Res. 33, e138.
38. MITCHELL, J.R., CHENG, J., and COLLINS, K. (1999). A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end. Mol. Cell Biol. 19, 567-576.
39. MOELLING, K., ABELS, S., JENDIS, J., MATSKEVICH, A., and HEINRICH, J. (2006). Silencing of HIV by hairpin-loop-structured DNA oligonucleotides. FEBS Lett. 580, 3454-3450.
40. NAKAMURA, T.M., MORIN, G.B., CHAPMAN, K.B., WEINRICH, S.L., ANDREWS, W.H., LINGNER, J., HARLEY, C.B., and CECH, T.R. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959.
41. NORTON, J.C., PIATYSZEK, M.A., WRIGHT, W.E., SHAY, J.W., and COREY, D.R. (1996). Inhibition of human telomerase activity by peptide nucleic acids. Nat. Biotechnol. 14, 615-619.
42. QI, H., LIN, C.P., FU, X., WOOD, L.M., LIU, A.A., TSAI, Y.C., CHEN, Y., BARBIERI, C.M., PILCH, D.S., and LIU, L.F. (2006). G-Quardruplexes induce apoptosis in tumor cells. Cancer Res. 66, 11808-11816.
43. REN, J.G., XIA, H.L., TIAN, Y.M., JUST, T., CAI, G.P., and DAI, R. (2001). Expression of telomerase inhibits hydroxyl radicalinduced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett. 488, 133-138.
44. SCHULTZ, J., PAVLOVIC, J., STRACK, B., NAWRATH, M., and MOELLING, K. (1999). Long-lasting antimetastatic efficiency of interleukin 12-encoding plasmid DNA. Hum. Gene Ther. 10, 407-417.
45. SHAY, J.W., and WRIGHT, W.E. (2002). Telomerase: a target for cancer therapeutics. Cancer Cells 2, 257-265.
46. VISTICA, D.T., SKEHAN, P., SCUDIERO, D., MONKS, A., PITTMAN, A., and BOYD, M.R. (1991). Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res. 51, 2515-2520.
47. WRIGHT, W.E., PIATYSZEK, M.A., RAINEY, W.E., BRYD, W., and SHAY, J.W. (1996). Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18, 173-179.
48. YATABE, N., KYO, S., KONDO, S., KANAYA, T., WANG, Z., MAIDA, Y., TAKAKURA, M., NAKAMURA, M., TANAKA, M., and INOUE, M. (2002). 2-5A antisense RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells. Cancer Gene Ther. 9, 624-630.
49. ZHANG, X., CHEN, Z., CHEN, Y., and Tong, T. (2003). Delivering antisense telomerase RNA by a hybrid adenovirus/adno-associated virus significantly suppress the malignant phenotype and enhances cell apoptosis of human breast cancer cells. Oncogene 22, 2405-2416.
50. ZHANG, X., MAR, V., ZHOU, W., HARRINGTON, L., and ROBINSON, M.O. (1999). Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 13, 2388-2399.
51. ZHANG, F.X., ZHANG, X.Y., FAN, D.M., DENG, Z.Y., YAN, Y., WU, H.P., and FAN, J.J. (2000). Antisense telomerase RNA induced human gastric cancer cell apoptosis. World J. Gastroenterol. 6, 430-432.